We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBCWW
376
SBC Medical Group Warrants
SBCWW
$2.65M
$13K ﹤0.01%
+136,661
New +$11.4K
CLRCW
377
DELISTED
ClimateRock Warrant
CLRCW
$13K ﹤0.01%
234,485
+600
+0.3% +$45
WEL.WS
378
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$13K ﹤0.01%
52,474
+41,600
+383% +$8.98K
MCAAW
379
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$13K ﹤0.01%
+225,000
New +$20.5K
FLFVW
380
DELISTED
Feutune Light Acquisition Corporation Warrant
FLFVW
$13K ﹤0.01%
+214,100
New +$10.7K
HCMAW
381
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$13K ﹤0.01%
185,485
+485
+0.3% +$53
ICPT
382
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$13K ﹤0.01%
+57,300
New +$923K
CHEAW
383
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
$13K ﹤0.01%
166,666
– –
CRECW
384
DELISTED
Crescera Capital Acquisition Corp Warrant
CRECW
$13K ﹤0.01%
149,300
+1,100
+0.7% +$124
PNTM.WS
385
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$13K ﹤0.01%
220,000
+190,700
+651% +$18.6K
GLS.WS
386
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$13K ﹤0.01%
262,979
+41,604
+19% +$3.27K
TEKKW
387
DELISTED
Tekkorp Digital Acquisition Corp. Warrant
TEKKW
$13K ﹤0.01%
+584,690
New +$60.7K
FVIV.WS
388
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$13K ﹤0.01%
75,999
– –
OSI.WS
389
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$12K ﹤0.01%
88,858
– –
LBBBW
390
DELISTED
Lakeshore Acquisition II Corp. Warrants
LBBBW
$12K ﹤0.01%
146,503
+3,603
+3% +$293
BIOSW
391
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$12K ﹤0.01%
149,950
+100
+0.1% +$11
LFACW
392
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$12K ﹤0.01%
200,200
– –
GLTA.WS
393
DELISTED
Galata Acquisition Corp. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
GLTA.WS
$12K ﹤0.01%
79,448
+16,949
+27% +$2.46K
VORBW
394
DELISTED
Virgin Orbit Holdings, Inc. Warrant
VORBW
$12K ﹤0.01%
+40,000
New +$20.4K
MSDAW
395
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$12K ﹤0.01%
90,000
+23,952
+36% +$5.26K
CDTTW
396
CDT Equity Inc Warrant
CDTTW
$1.63M
$11K ﹤0.01%
221,200
+20,000
+10% +$1.63K
CVIIW
397
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$11K ﹤0.01%
78,891
+50,650
+179% +$11.3K
MCACW
398
DELISTED
Monterey Capital Acquisition Corporation Warrants
MCACW
$11K ﹤0.01%
+200,400
New +$14.1K
SCRMW
399
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$11K ﹤0.01%
50,538
-8,800
-15% -$2.44K
ENCPW
400
DELISTED
Energem Corp Warrant
ENCPW
$11K ﹤0.01%
107,808
– –
14 15
16
17 18

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.